UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000040878
Receipt No. R000046678
Scientific Title A study to evaluate the effect after using baby diaperIX
Date of disclosure of the study information 2020/06/26
Last modified on 2020/12/07 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A study to evaluate the effect after using baby diaperIX
Acronym A study to evaluate the effect after using baby diaperIX
Scientific Title A study to evaluate the effect after using baby diaperIX
Scientific Title:Acronym A study to evaluate the effect after using baby diaperIX
Region
Asia(except Japan)

Condition
Condition Healthy infant
Classification by specialty
Dermatology Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect after using baby diaper
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Dermatological assessment before and after using diaper for 2, 4 weeks
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Single blind -investigator(s) and assessor(s) are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 4
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Sample(H) (2weeks)->Sample(J) (2weeks)
Interventions/Control_2 Sample(J) (2weeks)->Sample(H) (2weeks)
Interventions/Control_3 Sample(T) (2weeks)->Sample(S) (2weeks)
Interventions/Control_4 Sample(S) (2weeks)->Sample(T) (2weeks)
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
3 months-old <=
Age-upper limit
24 months-old >=
Gender Male and Female
Key inclusion criteria Healthy infant
Key exclusion criteria 1.Infant with skin disease
2.Infant with atopic dermatitis.
3.Infant diagnosed with chronic disease or congenital disorder.
4.Infant under-medication for their skin troubles.
5.Infant with diarrhea at screening.
Target sample size 120

Research contact person
Name of lead principal investigator
1st name Yuko
Middle name
Last name Fukuda
Organization Kao Corporation
Division name Sanitary Products Research
Zip code 321-3497
Address 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN
TEL 0285-68-7597
Email fukuda.yuuko1@kao.com

Public contact
Name of contact person
1st name Kazuhiko
Middle name
Last name Hayashi
Organization Kao Corporation
Division name Sanitary Products Research
Zip code 321-3497
Address 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN
TEL 0285-68-7913
Homepage URL
Email hayashi.kazuhiko@kao.com

Sponsor
Institute Kao Corporation
Institute
Department

Funding Source
Organization Kao Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Toyo Science Corp.
SMART Research Corp.
Children Hospital 2
Name of secondary funder(s)

IRB Contact (For public release)
Organization Human Research Ethics Committee, Kao Corporation
Address 2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN
Tel +81-3-5630-9220
Email morisaki.naoko@kao.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions Children Hospital 2(Vietnam)

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 119
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 01 Month 22 Day
Date of IRB
2020 Year 01 Month 22 Day
Anticipated trial start date
2020 Year 07 Month 20 Day
Last follow-up date
2020 Year 09 Month 18 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
2019 Year 12 Month 07 Day

Other
Other related information

Management information
Registered date
2020 Year 06 Month 24 Day
Last modified on
2020 Year 12 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046678